Your browser doesn't support javascript.
loading
Circulating T cell subsets are associated with clinical outcome of anti-VEGF-based 1st-line treatment of metastatic colorectal cancer patients: a prospective study with focus on primary tumor sidedness.
Bencsikova, Beatrix; Budinska, Eva; Selingerova, Iveta; Pilatova, Katerina; Fedorova, Lenka; Greplova, Kristina; Nenutil, Rudolf; Valik, Dalibor; Obermannova, Radka; Sheard, Michael A; Zdrazilova-Dubska, Lenka.
Afiliación
  • Bencsikova B; Department of Comprehensive Cancer Care, Masaryk Memorial Cancer Institute, Brno, Czech Republic.
  • Budinska E; Regional Centre for Applied Molecular Oncology, Masaryk Memorial Cancer Institute, Brno, Czech Republic.
  • Selingerova I; Regional Centre for Applied Molecular Oncology, Masaryk Memorial Cancer Institute, Brno, Czech Republic.
  • Pilatova K; Regional Centre for Applied Molecular Oncology, Masaryk Memorial Cancer Institute, Brno, Czech Republic.
  • Fedorova L; Department of Laboratory Medicine, Masaryk Memorial Cancer Institute, Brno, Czech Republic.
  • Greplova K; Regional Centre for Applied Molecular Oncology, Masaryk Memorial Cancer Institute, Brno, Czech Republic.
  • Nenutil R; Department of Laboratory Medicine, Masaryk Memorial Cancer Institute, Brno, Czech Republic.
  • Valik D; Department of Laboratory Medicine, Masaryk Memorial Cancer Institute, Brno, Czech Republic.
  • Obermannova R; Regional Centre for Applied Molecular Oncology, Masaryk Memorial Cancer Institute, Brno, Czech Republic.
  • Sheard MA; Department of Laboratory Medicine, Masaryk Memorial Cancer Institute, Brno, Czech Republic.
  • Zdrazilova-Dubska L; Regional Centre for Applied Molecular Oncology, Masaryk Memorial Cancer Institute, Brno, Czech Republic.
BMC Cancer ; 19(1): 687, 2019 Jul 15.
Article en En | MEDLINE | ID: mdl-31307428

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Linfocitos T Citotóxicos / Neoplasias Colorrectales / Adenocarcinoma / Linfocitos T Reguladores / Inhibidores de la Angiogénesis / Factor A de Crecimiento Endotelial Vascular / Bevacizumab / Metástasis de la Neoplasia Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: BMC Cancer Asunto de la revista: NEOPLASIAS Año: 2019 Tipo del documento: Article País de afiliación: República Checa

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Linfocitos T Citotóxicos / Neoplasias Colorrectales / Adenocarcinoma / Linfocitos T Reguladores / Inhibidores de la Angiogénesis / Factor A de Crecimiento Endotelial Vascular / Bevacizumab / Metástasis de la Neoplasia Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: BMC Cancer Asunto de la revista: NEOPLASIAS Año: 2019 Tipo del documento: Article País de afiliación: República Checa